KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Prepaid Assets (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Prepaid Assets for 17 consecutive years, with $27.7 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets fell 77.41% to $27.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $27.7 million through Dec 2025, down 77.41% year-over-year, with the annual reading at $27.7 million for FY2025, 77.41% down from the prior year.
  • Prepaid Assets for Q4 2025 was $27.7 million at Bio-Rad Laboratories, up from $23.5 million in the prior quarter.
  • The five-year high for Prepaid Assets was $149.6 million in Q2 2025, with the low at $10.1 million in Q4 2021.
  • Average Prepaid Assets over 5 years is $67.4 million, with a median of $35.6 million recorded in 2024.
  • The sharpest move saw Prepaid Assets skyrocketed 1130.84% in 2022, then plummeted 84.83% in 2023.
  • Over 5 years, Prepaid Assets stood at $10.1 million in 2021, then surged by 1130.84% to $124.2 million in 2022, then tumbled by 78.98% to $26.1 million in 2023, then surged by 369.73% to $122.6 million in 2024, then plummeted by 77.41% to $27.7 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $27.7 million, $23.5 million, and $149.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.